Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Esther Serra-Baldrich

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
European Journal of Dermatology : EJD|October 12, 2023
Pathogenic mechanisms underlying itch in atopic dermatitis: the emerging role of neuroimmune interactionsAugusto Escalante, Esther Serra-Baldrich
Pharmaceutics|February 25, 2023
Efficacy and Safety of JAK1 Inhibitor Abrocitinib in Atopic DermatitisHelena Iznardo, Esther Roé, Esther Serra-Baldrich, et al.
Frontiers in Medicine|April 30, 2026
Experience in the management of real-world patients with chronic prurigo nodularis in a dermatology setting: results from the ECOSPIN Spanish survey-based studyIgnasi Figueras-Nart, Rafael Ortiz Castillo, Esther Serra Baldrich
Nefrologia|July 21, 2024
Information and consensus document for the diagnostic and therapeutic management of pruritus associated with chronic kidney disease in patients on haemodialysis in SpainJuan Manuel Buades, Ignasi Figueras-Nart, Marian Goicoechea, et al.
International Journal of Dermatology|September 10, 2025
Vaccination Recommendations in Patients With Atopic Dermatitis Treated With JAK InhibitorsMariano Ara-Martín, Carolina Moreno, Ricardo Ruiz-Villaverde, et al.
Dermatology and Therapy|June 5, 2026
The State of the Art in Chronic Prurigo NodularisEsther Serra-Baldrich, Ángeles Flórez, Marc Julià Manresa, et al.
Advances in Therapy|April 7, 2025
Baseline Characteristics and Treatment Patterns of Patients with Atopic Dermatitis Treated with Oral Systemic Therapies: An Interim Analysis of the AD-REAL StudyMatthias Augustin, Esther Serra-Baldrich, Julien Seneschal, et al.
Dermatology and Therapy|May 11, 2022
Indirect Treatment Comparison of Baricitinib versus Dupilumab in Adults with Moderate-to-Severe Atopic DermatitisMarjolein S de Bruin-Weller, Esther Serra-Baldrich, Sebastien Barbarot, et al.
Dermatology and Therapy|April 26, 2021
Itch and Sleep Improvements with Baricitinib in Patients with Atopic Dermatitis: A Post Hoc Analysis of 3 Phase 3 StudiesTimo Buhl, David Rosmarin, Esther Serra-Baldrich, et al.
Dermatology and Therapy|November 12, 2021
Efficacy of Dupilumab in Atopic Dermatitis: The Patient's PerspectiveMarjolein de Bruin-Weller, Joseph F Merola, Chih-Ho Hong, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
European Journal of Dermatology : EJD|October 12, 2023
Pathogenic mechanisms underlying itch in atopic dermatitis: the emerging role of neuroimmune interactionsAugusto Escalante, Esther Serra-Baldrich
Pharmaceutics|February 25, 2023
Efficacy and Safety of JAK1 Inhibitor Abrocitinib in Atopic DermatitisHelena Iznardo, Esther Roé, Esther Serra-Baldrich, et al.
Frontiers in Medicine|April 30, 2026
Experience in the management of real-world patients with chronic prurigo nodularis in a dermatology setting: results from the ECOSPIN Spanish survey-based studyIgnasi Figueras-Nart, Rafael Ortiz Castillo, Esther Serra Baldrich
Nefrologia|July 21, 2024
Information and consensus document for the diagnostic and therapeutic management of pruritus associated with chronic kidney disease in patients on haemodialysis in SpainJuan Manuel Buades, Ignasi Figueras-Nart, Marian Goicoechea, et al.
International Journal of Dermatology|September 10, 2025
Vaccination Recommendations in Patients With Atopic Dermatitis Treated With JAK InhibitorsMariano Ara-Martín, Carolina Moreno, Ricardo Ruiz-Villaverde, et al.
Dermatology and Therapy|June 5, 2026
The State of the Art in Chronic Prurigo NodularisEsther Serra-Baldrich, Ángeles Flórez, Marc Julià Manresa, et al.
Advances in Therapy|April 7, 2025
Baseline Characteristics and Treatment Patterns of Patients with Atopic Dermatitis Treated with Oral Systemic Therapies: An Interim Analysis of the AD-REAL StudyMatthias Augustin, Esther Serra-Baldrich, Julien Seneschal, et al.
Dermatology and Therapy|May 11, 2022
Indirect Treatment Comparison of Baricitinib versus Dupilumab in Adults with Moderate-to-Severe Atopic DermatitisMarjolein S de Bruin-Weller, Esther Serra-Baldrich, Sebastien Barbarot, et al.
Dermatology and Therapy|April 26, 2021
Itch and Sleep Improvements with Baricitinib in Patients with Atopic Dermatitis: A Post Hoc Analysis of 3 Phase 3 StudiesTimo Buhl, David Rosmarin, Esther Serra-Baldrich, et al.
Dermatology and Therapy|November 12, 2021
Efficacy of Dupilumab in Atopic Dermatitis: The Patient's PerspectiveMarjolein de Bruin-Weller, Joseph F Merola, Chih-Ho Hong, et al.
Pageof 5